{"id":"W4207041654","doi":"10.1093/ecco-jcc/jjab232.024","title":"OP25 Patients with moderate to severe Crohn’s Disease with and without prior biologic failure demonstrate improved endoscopic outcomes with risankizumab: Results from phase 3 induction and maintenance trials","year":2022,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Placebo; Internal medicine; Subgroup analysis; Maintenance therapy; Crohn's disease; Randomized controlled trial; Population; Gastroenterology; Endoscopy; Surgery; Disease; Confidence interval; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004153411,0.0006746925,0.002087407,0.0002795274,0.0002744659,0.0008494306,0.0004032553,0.0006047301,0.001380842],"category_scores_gemma":[0.002338738,0.0002737144,0.002985502,0.0003610431,0.0005482156,0.0004906324,0.0004612254,0.0008944434,0.0001949307],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003358547,"about_ca_system_score_gemma":0.0006757376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006648784,"about_ca_topic_score_gemma":0.001842558,"domain_scores_codex":[0.9985406,0.0007281308,0.0001952869,0.0002081647,0.0001740466,0.0001537279],"domain_scores_gemma":[0.9983495,0.0004867265,0.0005921726,0.000174713,0.0001344124,0.000262512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8213139,0.003187279,0.06915013,0.001684949,0.01714908,0.000169427,0.0001910489,0.0005076411,0.01514875,0.00009624114,0.001331904,0.07006968],"study_design_scores_gemma":[0.2812782,0.2193417,0.4624897,0.0003536438,0.0248188,0.0006570793,0.0002764836,0.001027798,0.005310365,0.0003488123,0.004007363,0.0000901033],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9874452,0.01020126,0.0002382389,0.0001641288,0.00005823865,0.0003005797,0.0004230171,0.00002377646,0.001145508],"genre_scores_gemma":[0.9974762,0.001144862,0.0002309426,0.0001713209,0.00008473723,0.0001338249,0.0005618264,0.000002942745,0.0001933001],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004153411,"threshold_uncertainty_score":0.02196562,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01080992173712934,"score_gpt":0.2507236394952151,"score_spread":0.2399137177580858,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}